Literature DB >> 24006062

Chromatin immunoprecipitation assays for Myc and N-Myc.

Bonnie L Barrilleaux1, Rebecca Cotterman, Paul S Knoepfler.   

Abstract

Myc and N-Myc have widespread impacts on the chromatin state within cells, both in a gene-specific and genome-wide manner. Our laboratory uses functional genomic methods including chromatin immunoprecipitation (ChIP), ChIP-chip, and, more recently, ChIP-seq to analyze the binding and genomic location of Myc. In this chapter, we describe an effective ChIP protocol using specific validated antibodies to Myc and N-Myc. We discuss the application of this protocol to several types of stem and cancer cells, with a focus on aspects of sample preparation prior to library preparation that are critical for successful Myc ChIP assays. Key variables are discussed and include the starting quantity of cells or tissue, lysis and sonication conditions, the quantity and quality of antibody used, and the identification of reliable target genes for ChIP validation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24006062      PMCID: PMC4349432          DOI: 10.1007/978-1-62703-429-6_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  MYC recruits the TIP60 histone acetyltransferase complex to chromatin.

Authors:  Scott R Frank; Tiziana Parisi; Stefan Taubert; Paula Fernandez; Miriam Fuchs; Ho-Man Chan; David M Livingston; Bruno Amati
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

2.  Myc-binding-site recognition in the human genome is determined by chromatin context.

Authors:  Ernesto Guccione; Francesca Martinato; Giacomo Finocchiaro; Lucilla Luzi; Laura Tizzoni; Valentina Dall' Olio; Giuseppe Zardo; Clara Nervi; Loris Bernard; Bruno Amati
Journal:  Nat Cell Biol       Date:  2006-06-11       Impact factor: 28.824

3.  An efficient and economic enhancer mix for PCR.

Authors:  Markus Ralser; Robert Querfurth; Hans-Jörg Warnatz; Hans Lehrach; Marie-Laure Yaspo; Sylvia Krobitsch
Journal:  Biochem Biophys Res Commun       Date:  2006-07-05       Impact factor: 3.575

4.  Comparison of sample preparation methods for ChIP-chip assays.

Authors:  Henriette O'Geen; Charles M Nicolet; Kim Blahnik; Roland Green; Peggy J Farnham
Journal:  Biotechniques       Date:  2006-11       Impact factor: 1.993

5.  Myc influences global chromatin structure.

Authors:  Paul S Knoepfler; Xiao-yong Zhang; Pei Feng Cheng; Philip R Gafken; Steven B McMahon; Robert N Eisenman
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

6.  The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc.

Authors:  S B McMahon; M A Wood; M D Cole
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

7.  Repression of p15INK4b expression by Myc through association with Miz-1.

Authors:  P Staller; K Peukert; A Kiermaier; J Seoane; J Lukas; H Karsunky; T Möröy; J Bartek; J Massagué; F Hänel; M Eilers
Journal:  Nat Cell Biol       Date:  2001-04       Impact factor: 28.824

8.  N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor.

Authors:  Rebecca Cotterman; Victor X Jin; Sheryl R Krig; Jessica M Lemen; Alice Wey; Peggy J Farnham; Paul S Knoepfler
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

9.  PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.

Authors:  Alessio Zippo; Alessandra De Robertis; Riccardo Serafini; Salvatore Oliviero
Journal:  Nat Cell Biol       Date:  2007-07-22       Impact factor: 28.824

10.  Myc and Miz-1 have coordinate genomic functions including targeting Hox genes in human embryonic stem cells.

Authors:  Natalia Varlakhanova; Rebecca Cotterman; Keith Bradnam; Ian Korf; Paul S Knoepfler
Journal:  Epigenetics Chromatin       Date:  2011-11-04       Impact factor: 4.954

View more
  5 in total

1.  Histone H3.3 regulates dynamic chromatin states during spermatogenesis.

Authors:  Benjamin T K Yuen; Kelly M Bush; Bonnie L Barrilleaux; Rebecca Cotterman; Paul S Knoepfler
Journal:  Development       Date:  2014-08-19       Impact factor: 6.868

2.  FOXN3 Regulates Hepatic Glucose Utilization.

Authors:  Santhosh Karanth; Erin K Zinkhan; Jonathon T Hill; H Joseph Yost; Amnon Schlegel
Journal:  Cell Rep       Date:  2016-06-09       Impact factor: 9.423

3.  miR-29a Is Repressed by MYC in Pancreatic Cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2.

Authors:  Shatovisha Dey; Jason J Kwon; Sheng Liu; Gabriel A Hodge; Solaema Taleb; Teresa A Zimmers; Jun Wan; Janaiah Kota
Journal:  Mol Cancer Res       Date:  2019-10-29       Impact factor: 5.852

4.  mTORC1 promotes cell growth via m6A-dependent mRNA degradation.

Authors:  Sungyun Cho; Gina Lee; Brian F Pickering; Cholsoon Jang; Jin H Park; Long He; Lavina Mathur; Seung-Soo Kim; Sunhee Jung; Hong-Wen Tang; Sebastien Monette; Joshua D Rabinowitz; Norbert Perrimon; Samie R Jaffrey; John Blenis
Journal:  Mol Cell       Date:  2021-03-22       Impact factor: 19.328

5.  Iterative Fragmentation Improves the Detection of ChIP-seq Peaks for Inactive Histone Marks.

Authors:  Miklós Laczik; Jan Hendrickx; Anne-Clémence Veillard; Mustafa Tammoh; Sarah Marzi; Dominique Poncelet
Journal:  Bioinform Biol Insights       Date:  2016-10-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.